BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 10097743)

  • 21. [Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
    Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M
    Gan To Kagaku Ryoho; 1996 Nov; 23(13):1740-6. PubMed ID: 8937483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous infusion of 5-fluorouracil with versus without low-dose, consecutive administration of cisplatin in advanced colorectal cancer. A prospective randomized phase II study.
    Nakata B; Sowa M; Tsuji A; Kamano T; Sasaki K; Fukunaga Y; Takahashi M; Tsujitani S; Mikami Y; Mitachi Y; Nishimura S; Araki H; Yamamitsu S; Hirakawa K; Tominaga S; Shirasaka T; Inokuchi K
    J Exp Clin Cancer Res; 2007 Mar; 26(1):51-60. PubMed ID: 17550132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
    Yamasaki T; Kimura T; Kurokawa F; Aoyama K; Ishikawa T; Tajima K; Yokoyama Y; Takami T; Omori K; Kawaguchi K; Tsuchiya M; Terai S; Sakaida I; Okita K
    J Gastroenterol; 2005 Jan; 40(1):70-8. PubMed ID: 15692792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Trial of outpatient anti-cancer chemotherapy with infusion of 5-FU and cisplatin for advanced gastric and colorectal cancers].
    Suzuki H; Kanou Y; Ooshima H; Kawase J; Kudou J; Mizuno Y; Matsumoto S
    Gan To Kagaku Ryoho; 2005 Feb; 32(2):189-93. PubMed ID: 15751631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of low-dose FP therapy as adjuvant therapy for gastric cancer].
    Maeda Y; Sato Y; Yamamoto M; Shomura H; Honnma S; Kohashi S; Shinohara T; Takahashi S; Kondo M; Todo S
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):381-4. PubMed ID: 15791822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Low-dose FP (5-FU+low-dose CDDP) therapy for far advanced upper gastro-intestinal carcinoma].
    Nakamura M; Katano M; Yunotani S; Hisatsugu T; Sasadomi E; Masumoto H
    Gan To Kagaku Ryoho; 1995 Dec; 22(14):2081-6. PubMed ID: 8607619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combination chemotherapy with FP versus FEP in patients with advanced gastric cancer. Research group of gastric cancer chemotherapy].
    Shinoda M; Morise K; Kusugami K; Iwase H; Ina K; Kaneko H; Horiuchi Y; Kuroiwa A; Suga S; Oka Y
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):515-20. PubMed ID: 7887643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neoadjuvant chemotherapy in high-grade advanced gastric cancer with protracted infusional 5-fluorouracil and consecutive low-dose cisplatin].
    Kondo K; Murase M; Yokoyama Y; Kato J; Hibi K; Kasai Y; Akiyama S; Ito K; Takagi H
    Gan To Kagaku Ryoho; 1996 Sep; 23(10):1299-303. PubMed ID: 8831742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ambulatory and domiciliary cancer chemotherapy with forearm implant catheter system and low-dose CDDP + 5-FU therapy].
    Tsuji A; Morita S; Horimi T; Takasaki M; Takahashi I; Shirasaka T
    Gan To Kagaku Ryoho; 1999 Dec; 26 Suppl 2():326-32. PubMed ID: 10630242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Low-dose CDDP and 5-FU for head and neck cancer patients].
    Fujii M; Kanke M; Tomita T
    Gan To Kagaku Ryoho; 1999 Oct; 26(11):1542-7. PubMed ID: 10553410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Continuous arterial infusion of low-dose cisplatin, 5-fluorouracil as adjuvant therapy in cytoreductive surgery for advanced hepatocellular carcinoma].
    Ogata T; Okuda K; Tanaka S; Shibata J; Koga A; Kinoshita H; Nakayama T; Aoyagi S; Tanaka M; Tanikawa K
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1661-4. PubMed ID: 9382501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of gastric cancer with liver metastasis responding to low-dose CDDP/5-FU combination chemotherapy].
    Iwatani Y; Ohno M; Kamigaki T; Nakamura T; Suzuki Y; Iwasaki T; Sinmaru H; Hirata K; Kuroda Y
    Gan To Kagaku Ryoho; 2000 Feb; 27(2):277-80. PubMed ID: 10700900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study of serum CDDP concentrations in patients with advanced or recurrent adeno-or squamous cell carcinoma under combination chemotherapy of 5-FU (CIV) and low-dose CDDP (IV)].
    Yagihashi A; Sasaki K; Hirata K; Yamamitsu S
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):63-7. PubMed ID: 8546471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of advanced esophageal cancer showing good partial response by combination therapy of low dose 5-FU and low dose CDDP].
    Akagi T; Sakata Y; Takemori H; Kimura S; Kudoh I; Suzuki H; Fukushi M; Aisawa T; Ishiguro Y; Yoshiike M; Osanai S
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):103-6. PubMed ID: 8546458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoadjuvant chemotherapy in squamous cell carcinoma of the esophagus using low dose continuous infusion 5-fluorouracil and cisplatin: results of a prospective study.
    Aroori S; Parshad R; Kapoor A; Gupta SD; Kumar A; Chattophadyay TK
    Indian J Cancer; 2004; 41(1):3-7. PubMed ID: 15105572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination chemotherapy with continuous 5-fluorouracil and low-dose cisplatin infusion for advanced hepatocellular carcinoma.
    Tanioka H; Tsuji A; Morita S; Horimi T; Takamatsu M; Shirasaka T; Mizushima T; Ochi K; Kiura K; Tanimoto M
    Anticancer Res; 2003; 23(2C):1891-7. PubMed ID: 12820474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical study on the effect of 24-hour continuous intravenous infusion of CDDP in far-advanced and recurrent carcinoma of the gastrointestinal tract].
    Taoka H; Isaji S; Kosaka A; Mizumoto R; Andou Y
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1033-42. PubMed ID: 3032110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
    Kim R; Tanabe K; Inoue H; Toge T
    Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
    Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conceptual changes in cancer chemotherapy--biochemical modulation of 5-FU from bench to clinic.
    Shirasaka T
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():193-205. PubMed ID: 10895155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.